Year-end report 1 January - 31 December 2013
- Local currency sales decreased by 1% and Euro sales decreased by 10% to €371.2m (€410.6m).
- Number of active consultants increased by 1% to 3.5m.
- EBITDA amounted to €52.0m (€64.1m).
- Adjusted operating margin was 12.6% (13.7%) resulting in an adjusted operating profit of €46.8m (€56.2m).
- Adjusted net profit amounted to €27.2m (€37.2m) and adjusted EPS amounted to €0.49 (€0.65).
- Cash flow from operating activities amounted to €63.7m (€77.9m).
- First quarter update: The underlying sales development in the first quarter to date is around -3% in local currency.
12 months ended 31 December 2013
- Local currency sales decreased by 1% and Euro sales decreased by 6% to €1,406.7m (€1,489.3m).
- EBITDA amounted to €166.5m (€204.2m).
- Adjusted operating margin was 10.1% (11.8%) resulting in an adjusted operating profit of €142.4m (€175.1m).
- Adjusted net profit amounted to €84.4m (€121.5m) and adjusted EPS amounted to €1.52 (€2.13).
- Cash flow from operating activities amounted to €112.1m (€183.7m).
- The Board of Directors will propose a total dividend for 2013 of €1.00 (€1.75) per share, corresponding to 71 percent of net profit, as previously communicated paid in quarterly instalments, with the first payment amounting to €0.25 per share payable following the AGM on 19 May 2014.
For more information, click the link below
Oriflame Q4-2013
No comments:
Post a Comment